Glycine — Expert Claims
Extracted from publicly available podcast transcripts and videos. Each claim is attributed and sourced.
Claims are extracted using AI (Claude) from publicly available transcripts and manually reviewed. Extraction confidence (high / medium / low) indicates accuracy of capture. Each claim is compared against PubMed research.
3 expert mentions
"Glycine — about 3 grams — taken 30 to 60 minutes before sleep has some interesting evidence. It appears to lower core body temperature, and that drop in body temperature is one of the key signals that triggers the transition into sleep."
Glycine taken before sleep may improve sleep quality by lowering core body temperature, which is a key signal for sleep onset.
The thermoregulatory mechanism is supported by Bannai & Kawai (2012), who documented core body temperature reduction alongside improved sleep quality in small human trials. The effect is biologically plausible — distal vasodilation and heat dissipation are established sleep-onset signals. However, the studies are small (n=11 or fewer), and large-scale RCTs in diverse populations are lacking. The claim accurately characterizes the mechanistic picture without overstating the clinical certainty.
"Glutathione is the master antioxidant, and glycine is actually one of its three building blocks. What is interesting about the GlyNAC research is that it suggests older adults are deficient in both glycine and cysteine, and supplementing both together can dramatically raise glutathione and appears to correct several hallmarks of aging in that population."
Glycine combined with N-acetylcysteine (NAC) is a powerful precursor pair for glutathione synthesis, and the combination — GlyNAC — has emerging evidence for supporting longevity-related pathways in older adults.
The GlyNAC combination for glutathione is biochemically well-grounded — glycine and cysteine (from NAC) are two of three glutathione precursors. The Kumar et al. (2017) RCT data in older adults supports improvements across several aging biomarkers. However, the samples are small and the evidence is early-stage. Attributing longevity benefit to glycine alone (vs. the combination) is not yet separable from the RCT data. The claim is appropriately framed around the combination and emerging evidence.
"Glycine is one of those things I think deserves more attention. It's a conditionally essential amino acid, its safety profile is about as clean as anything you can take, and there's a reasonable argument that most people eating a modern diet are not getting enough of it because they're not eating the parts of the animal that are rich in collagen."
Glycine is an underrated amino acid with an unusually favorable safety profile and a plausible case for dietary insufficiency in modern diets, given how little collagen most people eat.
The conditional essentiality and dietary gap arguments are supported by Meléndez-Hevia et al. (2013), who modeled that endogenous glycine synthesis plus typical dietary intake may not meet full metabolic demand. The safety claim is well-supported — glycine is generally recognized as safe with no established Tolerable Upper Intake Level, and large doses (tens of grams per day) have been studied in schizophrenia research without serious adverse events. The framing is measured and appropriately stops short of specific therapeutic claims.